Healthcare stocks are on their biggest hot streak in a generation. Think twice before chasing the rally.
Published . Updated .
The typically boring healthcare space has delivered a flash of excitement for investors in October, building on its gains from earlier in the year.
Directly affected
- No company is named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- LLY Eli Lilly and+12.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- JNJ Johnson & Johnson+0.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- PFE Pfizer+8.4% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- MRK Merck-2.1% 15d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XLV | -0.15% | +0.03% | base | +0.67% | after close | after close | after close |
| XBI | -1.35% | -3.43% | base | +1.08% | after close | after close | after close |
| LLY | -0.83% | -0.57% | base | +1.02% | after close | after close | after close |
| JNJ | -4.13% | -1.82% | base | +1.00% | after close | after close | after close |
| PFE | +0.23% | +0.74% | base | -1.07% | after close | after close | after close |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
The typically boring healthcare space has delivered a flash of excitement for investors in October, building on its gains from earlier in the year.
Source: MarketWatch
This story
| Company | When | Move | Status |
|---|---|---|---|
| JNJ | that day | +1.00% | still updating |
| JNJ | three days earlier | -1.82% | final price |
| JNJ | five days earlier | -4.13% | final price |
| LLY | that day | +1.02% | still updating |
| LLY | three days earlier | -0.57% | final price |
| LLY | five days earlier | -0.83% | final price |
| PFE | that day | -1.07% | still updating |
| PFE | three days earlier | +0.74% | final price |
| PFE | five days earlier | +0.23% | final price |
| XBI | that day | +1.08% | still updating |
| XBI | three days earlier | -3.43% | final price |
| XBI | five days earlier | -1.35% | final price |
| XLV | that day | +0.67% | still updating |
| XLV | three days earlier | +0.03% | final price |
| XLV | five days earlier | -0.15% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 33 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 50 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 68 days before publication. Filed 8 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 31 Jul 2026. That is 89 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 70 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 89 days before publication. Filed 22 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100Price not final
“Healthcare stocks are on their biggest hot streak in a generation. Think twice before chasing the rally.” scores 12 out of 100. The score uses 1 sources. The price is not final yet.